Silicon Laboratories INC Form 4 insider transactions

Silicon Laboratories' Senior VP of Worldwide Sales & Marketing, Brandon Tolany, exercised stock options and subsequently sold a portion of the acquired common stock.

Silicon Laboratories' Senior VP and CFO, Dean Warren Butler, acquired 177 shares of common stock through the company's Employee Stock Purchase Plan.

Silicon Laboratories' Chief Accounting Officer, Mark D. Mauldin, acquired 21 shares of common stock through an employee stock purchase plan.

Brandon Tolany, Sr VP WW Sales & Marketing at Silicon Laboratories Inc., acquired 53 shares of common stock at $86.46 per share through the company's Employee Stock Purchase Plan.

Silicon Labs Senior VP Brandon Tolany exercised stock options and immediately sold an equivalent number of shares under a pre-arranged trading plan.

Brandon Tolany, Senior VP of Worldwide Sales & Marketing at Silicon Laboratories Inc., exercised stock options and immediately sold the acquired shares on August 22, 2025.

Silicon Labs Senior VP Brandon Tolany sold 2,270 shares of common stock after exercising stock options.

Mark D. Mauldin, Chief Accounting Officer of Silicon Laboratories, reports acquisition and disposal of company stock.

Brandon Tolany, Sr VP at Silicon Laboratories, reports acquisition and disposal of company stock, including shares from an employee stock purchase plan and restricted stock units.

Dean Warren Butler, CFO of Silicon Laboratories, reports acquisition and disposal of company stock, including shares from an employee stock purchase plan and restricted stock units.

Robert J. Conrad, a Senior VP and General Manager at Silicon Laboratories, reports acquisition and disposal of company stock, including grants of restricted stock units and sales under a 10b5-1 trading plan.

Robert Johnson, CEO of Silicon Laboratories, reports acquisition and disposal of company stock, including shares withheld for taxes and sales under a 10b5-1 trading plan.

Robert J. Conrad, Sr VP Worldwide Operations at Silicon Laboratories, sold 1,172 shares of common stock at $130 per share on May 13, 2025, under a pre-arranged 10b5-1 trading plan.

Director Christy Wyatt sold 546 shares of Silicon Laboratories (SLAB) at $104.45 per share on May 6, 2025, under a pre-arranged 10b5-1 trading plan.

Director Christy Wyatt received 1,843 restricted stock units and disposed of 9,038 common stock shares of Silicon Laboratories Inc. on April 24, 2025.

Director Gregg Lowe reports acquisition of 1,843 shares and disposal of 13,994 shares of Silicon Laboratories Inc. common stock on April 24, 2025, along with a grant of restricted stock units.

Director William G. Bock reports acquisition of 1,843 restricted stock units (RSUs) in Silicon Laboratories Inc.

Director Nina Richardson reports acquisition and disposal of Silicon Laboratories stock, including a grant of restricted stock units.

Director Sumit Sadana reports acquisition of 1,843 shares of Silicon Laboratories Inc. common stock through restricted stock units.

Director Navdeep Sooch reports acquiring 2,349 shares of Silicon Laboratories common stock through a grant of restricted stock units.

Director Sherri R. Luther reports acquiring 1,843 shares of Silicon Laboratories Inc. common stock through restricted stock units (RSUs).

Director William G. Bock sold 1,000 shares of Silicon Laboratories Inc. (SLAB) common stock on February 18, 2025, under a pre-arranged 10b5-1 trading plan.

Mark D. Mauldin, Chief Accounting Officer of Silicon Laboratories, reports disposition of shares to cover tax obligations upon vesting of an equity award.

Director Navdeep Sooch of Silicon Laboratories sold 2,640 shares of common stock at an average price of $149.08 per share on February 6, 2025, under a pre-arranged 10b5-1 trading plan.

Navdeep Sooch, a director at Silicon Laboratories Inc., sold 2,360 shares of common stock at a weighted average price of $149 per share on February 5, 2025, under a pre-arranged 10b5-1 trading plan.

William G. Bock, a director at Silicon Laboratories, sold 2,000 shares of common stock at an average price of $140.77 per share under a pre-arranged 10b5-1 trading plan.

Silicon Laboratories' Senior VP of WW Sales & Marketing, Brandon Tolany, sold 845 shares of common stock at $115 per share on September 3, 2024, under a pre-arranged 10b5-1 trading plan.

Silicon Laboratories CEO Robert Matthew Johnson sold 7,230 shares of common stock on June 3, 2024, under a pre-arranged 10b5-1 trading plan.

Dean Warren Butler, CFO of Silicon Laboratories, received grants of restricted stock units (RSUs) on May 15, 2024, according to a Form 4 filing with the SEC.

Robert J Conrad, Sr VP of Worldwide Operations at Silicon Laboratories, reports acquisition of common stock and restricted stock units.